Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Mt-3995
2. N-(4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2h-1,4-benzoxazin-7-yl)methanesulfonamide
1. 945966-46-1
2. Mt-3995
3. Apararenone [inn]
4. N-(4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2h-benzo[b][1,4]oxazin-7-yl)methanesulfonamide
5. Chembl2181929
6. 832663u2nb
7. Methanesulfonamide, N-(4-(4-fluorophenyl)-3,4-dihydro-2,2-dimethyl-3-oxo-2h-1,4-benzoxazin-7-yl)-
8. N-(4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2h-1,4-benzoxazin-7-yl)methanesulfonamide
9. N-[4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2h-1,4-benzoxazin-7-yl]methanesulfonamide
10. Apararenone [who-dd]
11. Schembl753911
12. Unii-832663u2nb
13. Gtpl12039
14. Dtxsid401337181
15. Glxc-25862
16. Vmb96646
17. Bdbm50004519
18. Mfcd31657369
19. Mt3995
20. Akos037649320
21. Db15024
22. Compound 39 [pmid: 35652647]
23. Bs-18041
24. Hy-109002
25. Cs-0030433
26. D80760
27. Q27269381
28. N-[4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-1,4-benzoxazin-7-yl]methanesulfonamide
29. N-[4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2h -1,4-benzoxazin-7-yl]methanesulfonamide
30. N-[4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2h-1,4-benzooxazine-7-yl]methanesulfonamide
| Molecular Weight | 364.4 g/mol |
|---|---|
| Molecular Formula | C17H17FN2O4S |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 364.08930636 g/mol |
| Monoisotopic Mass | 364.08930636 g/mol |
| Topological Polar Surface Area | 84.1 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 611 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
70
PharmaCompass offers a list of Apararenone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Apararenone manufacturer or Apararenone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Apararenone manufacturer or Apararenone supplier.
PharmaCompass also assists you with knowing the Apararenone API Price utilized in the formulation of products. Apararenone API Price is not always fixed or binding as the Apararenone Price is obtained through a variety of data sources. The Apararenone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Apararenone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apararenone, including repackagers and relabelers. The FDA regulates Apararenone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apararenone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Apararenone supplier is an individual or a company that provides Apararenone active pharmaceutical ingredient (API) or Apararenone finished formulations upon request. The Apararenone suppliers may include Apararenone API manufacturers, exporters, distributors and traders.
Apararenone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apararenone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apararenone GMP manufacturer or Apararenone GMP API supplier for your needs.
A Apararenone CoA (Certificate of Analysis) is a formal document that attests to Apararenone's compliance with Apararenone specifications and serves as a tool for batch-level quality control.
Apararenone CoA mostly includes findings from lab analyses of a specific batch. For each Apararenone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apararenone may be tested according to a variety of international standards, such as European Pharmacopoeia (Apararenone EP), Apararenone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apararenone USP).
